Skip to content
OpenCapital
Get started

Axsome Therapeutics AXSM Balipodect — Eligible Milestone Payments

Similar metrics at other companies

Biogen logo
BIIBQALSODY — Estimated additional payments upon achievement of development and commercial milestones
$20M—
Neurocrine Biosciences logo
NBIXDevelopment Product Candidates — Potential milestone payments
$620M—
Biogen logo
BIIBADUHELM — Additional milestone payment
$0—
Neurocrine Biosciences logo
NBIXLicense — Potential milestone payment receipts
$55M—
Neurocrine Biosciences logo
NBIXRoyalty — Potential milestone payment receipts
$366M—
Biogen logo
BIIBADUHELM — Potential future milestone payments commitment to third party approximately
$100M0.0%

Other financials

Income statement

See full
Revenue$191.2M+57.4%
Gross profit$176.5M+58.0%
Operating income-$63.4M-11.2%
Net income-$64.5M-8.6%
EPS (diluted)-$1.26-3.3%

Balance sheet

See full
Cash & equivalents$305.1M+1.4%
Total debt$219.9M+4.1%
Total equity$54.6M+2.6%
Total assets$713.6M+19.6%

Cash flow

See full
Operating cash flow-$20.7M+52.3%
CapEx$121.0K-64.2%
Free cash flow-$20.8M+52.4%

Valuation

See full
Market cap$12.89B+52.0%
Enterprise value$12.81B+52.9%
P/S18.2×-1.4×

Profitability

See full
Gross margin92.6%+1.1pp
Operating margin-24.4%-9.3pp
Net margin-26.6%-9.8pp
FCF margin-10.2%-3.9pp

Returns & leverage

See full
Return on equity-349.4%+109pp
Debt / equity4×+0.1×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Axsome Therapeutics in its filing.

Tagged under the XBRL concept axsm:EligibleMilestonePayments.

The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axsome Therapeutics's balipodect — eligible milestone payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axsome Therapeutics's balipodect — eligible milestone payments?
Axsome Therapeutics (AXSM) reported balipodect — eligible milestone payments of $260M in Q1 2026.
What does balipodect — eligible milestone payments mean?
The total amount of future payments contingent upon reaching specific development or commercial goals for Balipodect.
How do you interpret balipodect — eligible milestone payments?
Higher values indicate a larger pipeline of potential future liabilities, which may signal high-stakes development progress or significant future cash outflows upon success.
How does balipodect — eligible milestone payments compare across companies?
Similar to contingent consideration or milestone obligations found in licensing agreements across the biotechnology industry.